You have 9 free searches left this month | for more free features.

GVHD (acute or chronic)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

Dendritic Cells in Acute or Chronic Skin Graft Versus Host

Recruiting
  • Acute Graft-versus-host Disease
  • +3 more
  • Skin punch biopsy
  • Peripheral blood draw
  • Saint Louis, Missouri
    Washington University School of Medicine
May 31, 2022

GVHD,Acute, GVHD, Chronic Trial in Salamanca (Physical exercise)

Recruiting
  • GVHD,Acute
  • GVHD, Chronic
  • Physical exercise
  • Salamanca, Spain
    University of Salamanca
May 27, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Bone Marrow Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult Trial in Indianapolis

Not yet recruiting
  • Bone Marrow Transplant Complications
  • +4 more
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
May 30, 2023

GVHD Trial in Ramat Gan (Cyclophosphamide, anti-human T-lymphocyte immunoglobulin (ATLG))

Recruiting
  • Graft Versus Host Disease
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
May 4, 2022

Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention

Recruiting
  • Graft Vs Host Disease
  • +2 more
  • Exercise
  • Attention control
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
Dec 21, 2021

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +16 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 1, 2022

GVHD Trial (Grafalon, Thymoglobulin)

Not yet recruiting
  • GVHD
  • (no location specified)
Oct 9, 2023

Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

Not yet recruiting
  • Graft Vs Host Disease
  • Vandoeuvre Les Nancy, France
    CHRU de Nancy
Nov 10, 2023

Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)

Completed
  • Non-Hodgkin's Lymphoma
  • +7 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021

Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

Not yet recruiting
  • Allogeneic Disease
  • +2 more
  • WJ-MSC infusion
  • (no location specified)
May 4, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Cleveland (tacrolimus, methotrexate,

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • +9 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 4, 2021

Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)

Recruiting
  • Chronic Graft-Versus-Host Disease
  • +2 more
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Apr 27, 2021

GVHD, Acute GVHD, Chronic GVHD Trial in Atlanta (Autologous mesenchymal stromal cells (MSCs))

Completed
  • Graft Versus Host Disease
  • +2 more
  • Autologous mesenchymal stromal cells (MSCs)
  • Atlanta, Georgia
    Children's Healthcare of Atlanta/Emory University
Mar 2, 2021

Acute GVHD Trial (MTX, Corticosteroid)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Jun 26, 2023

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Atorvastatin, Methotrexate,

Withdrawn
  • Acute Myeloid Leukemia
  • +2 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

ECP Combination Study

Active, not recruiting
  • Steroid Refractory GVHD
  • Antwerp, Belgium
  • +37 more
Jun 17, 2022

Acute Lymphoblastic Leukemia (ALL) in Partial Remission, Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia (ALL) in Partial Remission
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Center
Apr 4, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

GVHD, Chronic, Acute Leukemia, Stem Cell Transplant Complications Trial in Bologna

Completed
  • GVHD, Chronic
  • +2 more
    • Bologna, Bo, Italy
      Hematology - Sant'Orsola-Malpighi Hospital
    Mar 18, 2021